Varsha Gandhi, PhD, on Ibrutinib

First International Summit on Interventional Pharmacoeconomics

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Opening Session Panel Discussion

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Issues in Oncology

Cost of Care

The ASCO Post Staff

Mark J. Ratain, MD, and Daniel Goldstein, MD, on Value in Cancer Care: How the Paradigm Is Shifting

Mark J. Ratain, MD, of the University of Chicago, and Daniel Goldstein, MD, of the Rabin Medical Center, discuss the challenges of achieving cancer care value, evolution of the “more-is-better” philosophy when it comes to oncology drugs, and highlights of the First International Summit on Interventional Pharmacoeconomics.

Apr

Today In Oncology

Varsha Gandhi, PhD, on Ibrutinib

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Opening Session Panel Discussion

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Mark J. Ratain, MD, and Daniel Goldstein, MD, on Value in Cancer Care: How the Paradigm Is Shifting

Financial Hardship and Late-Stage Cancer Diagnosis

Agent Orange Exposure Linked to MDS Risk and Progression

One-Time Low-Dose CT Screening May Reduce Lung Cancer Mortality Among Neversmokers in Asia

Low-Risk Endometrial Cancer Does a Lack of Adjuvant Therapy Affect Survival

ctDNA at the End of Neoadjuvant Therapy May Predict Breast Cancer Recurrence